07:00 , Jul 21, 2008 |  BC Week In Review  |  Company News

Znomics board of directors update

Znomics Inc. (OTCBB:ZNOM), Portland, Ore.   Business: Functional genomics, Supply/Service   Appointed: Charles Blitzer, former president and CEO of Barbeau Pharma Inc.  ...
07:00 , Oct 10, 2005 |  BC Week In Review  |  Company News

Barbeau management update

Barbeau Pharma Inc. , Northfield, Ill.   Business: Drug delivery   Hired: Charles Blitzer as president and CEO, formerly president and CEO of Fulcrum Pharmaceuticals Inc.  ...
07:00 , Apr 26, 2004 |  BC Week In Review  |  Clinical News

Hydralazine regulatory update

FDA granted Orphan Drug designation for the companies' Hydra-lazine peripheral vasodilator to treat severe intrapartum hypertension associated with severe preeclampsia and eclampsia of pregnancy. Barbeau Pharma Inc. , Northfield, Ill.   ESP Pharma Inc. ,...